化合物详情

CAS59729-37-2
分子式C12H13N3O3S
分子量279.31 g/mol g/mol
危化品

Human African trypanosomiasis (HAT, also colloquially referred to as sleeping sickness), caused by T. brucei gambiense and T. brucei rhodesiense, remains a moderate risk (>1/10,000 inhabitants per year in endemic areas) despite focussed control efforts. Transmitted by the bite of an infected tsetse fly, HAT is biphasic with a first (hemolymphatic) stage that progresses to a second (meningoencephalitic) stage in which patients experience progressively worsening neurological symptoms and eventually die if left untreated. Historical treatment options for meningoencephalitic HAT include [melarsoprol], [eflornithine], and [nifurtimox]/[eflornithine] combination therapy (NECT), though [melarsoprol] is highly toxic and each treatment requires lengthy infusions that are difficult to administer...

科学粮草官-词典编辑部,修订于:2026-07-06

化合物详情

Toxicity

Toxicity
3
Hepatotoxicity
Likelihood score: E* (unlikely but suspected cause of clinically apparent liver injury when given in the recommended regimens for African trypanosomiasis).
Drug Induced Liver Injury
References: DOI:10.1016/j.drudis.2016.02.015
Effects During Pregnancy and Lactation
Relevant published information was not found as of the revision date.
客服